Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 242 of the 244 references it cites were found in a registry or an index.
Abstract
Mitochondria play a central role in a plethora of processes related to the maintenance of cellular homeostasis and genomic integrity. They contribute to preserving the optimal functioning of cells and protecting them from potential DNA damage which could result in mutations and disease. However, perturbations of the system due to senescence or environmental factors induce alterations of the physiological balance and lead to the impairment of mitochondrial functions. After the description of the crucial roles of mitochondria for cell survival and activity, the core of this review focuses on the “mitochondrial switch” which occurs at the onset of neuronal degeneration. We dissect the pathways related to mitochondrial dysfunctions which are shared among the most frequent or disabling neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s, Amyotrophic Lateral Sclerosis, and Spinal Muscular Atrophy. Can mitochondrial dysfunctions (affecting their morphology and activities) represent the early event eliciting the shift towards pathological neurobiological processes? Can mitochondria represent a common target against neurodegeneration? We also review here the drugs that target mitochondria in neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Mitochondrial dysfunction has been reported in a number of neurodegenerative diseases [3–6] and correlates with dendritic pathology and synapse disassembly [7–10].”
From AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma (2021) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kandimalla, R., Manczak, M., Yin, X., Wang, R., & Reddy, P. H. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx381 · Cited by 260 · cited 1×
“Neurodegenerative diseases consist of a group of heterogeneous disorders, but, nevertheless, they are all characterized by the progressive loss of specific neuronal populations and circuits in the central nervous system (CNS) triggered by mitochondria dysfunctions [23,24].”
BackgroundRetractedFree Radicals in Biology and Medicine
Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“Additionally, also in PD, mitochondrial dysfunctions are not limited to CNS, but also involve peripheral tissues as it has been described in skeletal muscles and platelets [62,75].”
BackgroundThe amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · cited 1×
“AD is the most common and devastating neurodegenerative disease expected to affect more than 81 million people worldwide by 2040 [41,42].”
BackgroundA role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602 · cited 1×
“Interestingly, NLRP3 localizes in the cytosol and once activated it translocates into mitochondria and mitochondria-associated membranes (MAMs) [37].”
BackgroundGlobal prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 1×
“AD is the most common and devastating neurodegenerative disease expected to affect more than 81 million people worldwide by 2040 [41,42].”
BackgroundChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · cited 1×
“The first evidence of mitochondrial dysfunction in PD came in 1983, when Langston described chronic parkinsonism effects in young humans after the use of 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP), which is a prodrug to the neurotoxin 1-methyl-4-phenylpyridinium (MPP+); the latter interferes with the activity…”
BackgroundOxidative Stress: Harms and Benefits for Human Health
Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8416763 · Cited by 4,837
Mitochondrial Fission, Fusion, and Stress
Youle, R. J., & van der Bliek, A. M. (2012) · Science · doi:10.1126/science.1219855 · Cited by 3,674 · cited 1×
“Indeed, the processes of fusion and fission are fundamental, respectively, to repair a damaged mitochondrion or to increment their number, as in case of an increased demand of energy or to facilitate their removal when damaged in order to protect cellular integrity [12].”
BackgroundWallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185 · cited 2×
“Classically, mitochondria were considered the “powerhouse” of the cell, the energetic core generating ATP for cell activities [1].”
BackgroundMcGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · cited 1×
“Moreover, neuroinflammation plays a role in PD; reactive microglia in the substantia nigra together with positron emission tomography (PET) imaging studies of PD brains provided early evidence for the role of neuroinflammation in PD [59,60].”
BackgroundTDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., & Sheu, S.-S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2004 · Cited by 2,575 · cited 1×
“Disturbances in calcium homeostasis and calcium overload could force the opening of the mitochondrial permeabilization transition pore, resulting in ROS formation, Cyt C release, and apoptosis activation [70].”
BackgroundMutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C., Rogelj, B., Hortobágyi, T., De Vos, K. J., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,564
(2001) · PubMed · Cited by 2,381
Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., et al. (2005) · Nature · doi:10.1038/nature03434 · Cited by 2,280
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233 · cited 1×
“Mitochondrial dysfunctions in PD are also a result of changes in mitochondria biogenesis caused by the dysregulation of transcription factors such as the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), as demonstrated both in mice and humans [71,72].”
BackgroundNeuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227 · cited 1×
“Patients show impairments in behavior, muscle coordination, and a progressive mental decline leading to death [76].”
BackgroundMitochondrial DNA stress primes the antiviral innate immune response
West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M., Bestwick, M., Duguay, B. A., Raimundo, N., MacDuff, D. A., et al. (2015) · Nature · doi:10.1038/nature14156 · Cited by 1,975 · cited 1×
“Finally, mitochondria are also able to protect cell integrity by preventing the damage induced by viral infection [16]; indeed, they can also stimulate the innate immune response against these insults [17].”
Background[36] Flavonoids as antioxidants: Determination of radical-scavenging efficiencies
Bors, W., Heller, W., Michel, C., & Saran, M. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86128-i · Cited by 1,723
Melatonin as an antioxidant: under promises but over delivers
Reiter, R. J., Mayo, J. C., Tan, D., Sainz, R. M., Alatorre‐Jimenez, M., & Qin, L. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12360 · Cited by 1,703
Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570 · cited 1×
“Inclusions of Lewy bodies and presence of immunoreactive α-synuclein and ubiquitin are also hallmarks of the disease [58].”
BackgroundGorman, G. S., Chinnery, P. F., DiMauro, S., Hirano, M., Koga, Y., McFarland, R., Suomalainen, A., Thorburn, D. R., Zeviani, M., & Turnbull, D. M. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.80 · Cited by 1,563
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
Mechanisms of mitophagy in cellular homeostasis, physiology and pathology
Palikaras, K., Lionaki, E., & Tavernarakis, N. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0176-2 · Cited by 1,472 · cited 1×
“, the process of mitochondria degradation by autophagy [14], aiming to maintain the correct turnover of mitochondria [15].”
BackgroundPotential Role of Carotenoids as Antioxidants in Human Health and Disease
Fiedor, J., & Burda, K. (2014) · Nutrients · doi:10.3390/nu6020466 · Cited by 1,420
Mitochondrial ROS Signaling in Organismal Homeostasis
Shadel, G. S., & Horvath, T. L. (2015) · Cell · doi:10.1016/j.cell.2015.10.001 · Cited by 1,353 · cited 1×
“Mitochondria are also the main generators of the reactive oxygen species (ROS) [6] and they participate to cell proliferation by maintaining a proper redox state and by recycling oxidized electron carriers.”
BackgroundLemasters, J. J. (2005) · Rejuvenation Research · doi:10.1089/rej.2005.8.3 · Cited by 1,340 · cited 1×
“, the process of mitochondria degradation by autophagy [14], aiming to maintain the correct turnover of mitochondria [15].”
BackgroundMitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B.-S., Kroemer, G., & Galluzzi, L. (2018) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,273 · cited 1×
“Indeed, besides human hereditary diseases caused by mutations of the mtDNA or in nuclear genes responsible for mitochondrial deregulation [18], mitochondrial dysfunctions are among the first events which occur in a vast number of pathological conditions ranking from diabetes [19], inflammatory diseases (such as multip…”
BackgroundIn vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200 · cited 1×
“Moreover, neuroinflammation plays a role in PD; reactive microglia in the substantia nigra together with positron emission tomography (PET) imaging studies of PD brains provided early evidence for the role of neuroinflammation in PD [59,60].”
BackgroundDetection and interpretation of shared genetic influences on 42 human traits
Pickrell, J. K., Berisa, T., Liu, J. Z., Ségurel, L., Tung, J. Y., & Hinds, D. A. (2016) · Nature Genetics · doi:10.1038/ng.3570 · Cited by 1,151
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Schroder, K., Zhou, R., & Tschopp, J. (2010) · Science · doi:10.1126/science.1184003 · Cited by 1,134
Role of Mitochondrial Dysfunction in Insulin Resistance
Kim, J.-A., Wei, Y., & Sowers, J. R. (2008) · Circulation Research · doi:10.1161/circresaha.107.165472 · Cited by 1,103 · cited 1×
“Indeed, besides human hereditary diseases caused by mutations of the mtDNA or in nuclear genes responsible for mitochondrial deregulation [18], mitochondrial dysfunctions are among the first events which occur in a vast number of pathological conditions ranking from diabetes [19], inflammatory diseases (such as multip…”
Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells
Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., & Murphy, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009093200 · Cited by 1,091
Mitochondrial Fusion and Fission in Mammals
Chan, D. C. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104638 · Cited by 972 · cited 1×
“Moreover, mitochondria are vital and dynamic organelles able to modify their shape and size in order to respond to the cellular needs and, therefore, to maintain cellular homeostasis [4].”
BackgroundThe changing scene of amyotrophic lateral sclerosis
Robberecht, W., & Philips, T. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3430 · Cited by 957
Microglial Activation and its Implications in the Brain Diseases
Thameem Dheen, S., Kaur, C., & Ling, E.-A. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707780597961 · Cited by 952
The chemistry and biological activities of N-acetylcysteine
Samuni, Y., Goldstein, S., Dean, O. M., & Berk, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.016 · Cited by 876
Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms
Kerr, J. S., Adriaanse, B. A., Greig, N. H., Mattson, M. P., Cader, M. Z., Bohr, V. A., & Fang, E. F. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.01.002 · Cited by 870 · cited 1×
“Moreover, alterations in mitochondrial dynamics appear early in AD development, contributing to impair neuronal autophagy because of defective mitophagy [50].”
BackgroundPGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease
Zheng, B., Liao, Z., Locascio, J. J., Lesniak, K. A., Roderick, S. S., Watt, M. L., Eklund, A. C., Zhang-James, Y., Kim, P. D., Hauser, M. A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001059 · Cited by 857 · cited 1×
“Mitochondrial dysfunctions in PD are also a result of changes in mitochondria biogenesis caused by the dysregulation of transcription factors such as the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), as demonstrated both in mice and humans [71,72].”
BackgroundMitochondrial dysfunction in Parkinson's disease
Bose, A., & Beal, M. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13731 · Cited by 841 · cited 1×
“Mitochondrial dysfunctions are related to both sporadic and familial PD and are associated to disturbances of mitochondrial function, morphology, and dynamics (for a detailed review see Bose and Beal [66]).”
BackgroundN-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why
Aldini, G., Altomare, A., Baron, G., Vistoli, G., Carini, M., Borsani, L., & Sergio, F. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1468564 · Cited by 830
Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777 · cited 1×
“Oxidative stress-induced damage occurs even before amyloid and tau deposition, and mitochondrial dysfunctions are early events which precede neurodegeneration [45].”
BackgroundALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Mejzini, R., Flynn, L. L., Pitout, I. L., Fletcher, S., Wilton, S. D., & Akkari, P. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01310 · Cited by 755
Paumgartner, G., & Beuers, U. (2002) · Hepatology · doi:10.1053/jhep.2002.36088 · Cited by 748
Keeney, P. M., Xie, J., Capaldi, R. A., & Bennett, J. P. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0984-06.2006 · Cited by 747 · cited 1×
“High levels of ROS, due to the high metabolic demand, determine accumulation of toxic oxidative species and structural alterations of complex I, affecting mitochondria functionality in patient brains and mouse models [67,68].”
BackgroundInactivation of the Mouse Huntington's Disease Gene Homolog Hdh
Duyao, M. P., Auerbach, A. B., Ryan, A., Persichetti, F., Barnes, G. T., McNeil, S. M., Ge, P., Vonsattel, J.-P., Gusella, J. F., Joyner, A. L., et al. (1995) · Science · doi:10.1126/science.7618107 · Cited by 723 · cited 1×
“However, the HTT gene is ubiquitously expressed [85] and in HD there are important dysfunctions occurring outside the brain.”
BackgroundResveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
Moussa, C., Hebron, M., Huang, X., Ahn, J., Rissman, R. A., Aisen, P. S., & Turner, R. S. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0779-0 · Cited by 705
Chen, Z., & Zhong, C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.004 · Cited by 673 · cited 1×
“Mitochondria appear morphologically and functionally altered, impacting on many processes such as excessive ROS formation, and resulting in the decrease of brain energy because of the reduction of ATP [47], alteration of calcium homeostasis, and of apoptosis induction [48]: indeed, altered levels of apoptotic markers…”
BackgroundImmunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.
Kawamata, T., Akiyama, H., Yamada, T., & McGeer, P. L. (1992) · PubMed Central · Cited by 660
Gurney, M. E., Cutting, F. B., Zhai, P., Doble, A., Taylor, C. P., Andrus, P. K., & Hall, E. D. (1996) · Annals of Neurology · doi:10.1002/ana.410390203 · Cited by 645
Cholinesterase inhibitors as Alzheimer's therapeutics (Review)
Sharma, K. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10374 · Cited by 602
Inflammasomes in carcinogenesis and anticancer immune responses
Zitvogel, L., Kepp, O., Galluzzi, L., & Kroemer, G. (2012) · Nature Immunology · doi:10.1038/ni.2224 · Cited by 593 · cited 1×
“Closely related to ROS and DAMP formation, another largely studied mechanism by which mitochondria drive neuroinflammation is their ability to activate the NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome [35], in turn leading to the release of proinflammatory cytokines [36].”
BackgroundThe role of mitochondria in amyotrophic lateral sclerosis
Smith, E. F., Shaw, P. J., & De Vos, K. J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2017.06.052 · Cited by 559 · cited 3×
“, OPA1, Mitofusin for fusion, and Fis1 and DRP1 for fission) [100], were observed and (iii) apoptotic signaling is impacted in different ALS models.”
BackgroundInfluentialMitochondrial Trafficking in Neurons
Schwarz, T. L. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011304 · Cited by 525 · cited 1×
“Due to the low potential of neural regeneration, mitochondrial damage results in detrimental effects for neuron survival [25], while in peripheral cells the regeneration capacity is higher and clinical symptoms are evident only later in the disease.”
BackgroundNeurodegenerative Diseases: An Overview of Environmental Risk Factors
Brown, R. C., Lockwood, A. H., & Sonawane, B. R. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7567 · Cited by 512
Pasinelli, P., Belford, M. E., Lennon, N., Bacskai, B. J., Hyman, B. T., Trotti, D., & Brown, R. H. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.021 · Cited by 506 · cited 3×
“In ALS, the apoptotic cascade is activated [101] and the mutant SOD1 is playing a major role in this cascade by interacting with Bcl-2 [102].”
BackgroundPolyphenols and glutathione synthesis regulation
Moskaug, J. Ø., Carlsen, H., Myhrstad, M. C., & Blomhoff, R. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.277s · Cited by 494
Dubowitz, V. (2015) · Muscular Dystrophy 1976 · doi:10.1159/000400687 · Cited by 483
Reich, S. G., & Savitt, J. M. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.10.014 · Cited by 483
Veitch, D. P., Weiner, M. W., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Morris, J. C., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.005 · Cited by 454
ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment?
Petrov, D., Mansfield, C., Moussy, A., & Hermine, O. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00068 · Cited by 451
Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases
Trushina, E., & McMurray, C. T. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.056 · Cited by 439 · cited 1×
“In particular, mitochondrial dysfunctions (both affecting neuronal survival and triggering neuroinflammation) have been reported in Alzheimer’s (AD), Parkinson’s (PD), and Huntington’s (HD) diseases, Amyotrophic Lateral Sclerosis (ALS), and Spinal Muscular Atrophy (SMA), thus representing a potential biomarker of the…”
BackgroundGenome-wide expression profiling of human blood reveals biomarkers for Huntington's disease
Borovecki, F., Lovrecic, L., Zhou, J., Jeong, H., Then, F., Rosas, H. D., Hersch, S. M., Hogarth, P., Bouzou, B., Jensen, R. V., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504921102 · Cited by 414 · cited 1×
“In this regard, impaired uptake and levels of glucose and cardiac dysfunctions have been shown in HD mouse models [86,87].”
BackgroundN‐acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities
Bavarsad Shahripour, R., Harrigan, M. R., & Alexandrov, A. V. (2014) · Brain and Behavior · doi:10.1002/brb3.208 · Cited by 410
Parkin and PINK1: much more than mitophagy
Scarffe, L. A., Stevens, D. A., Dawson, V. L., & Dawson, T. M. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.03.004 · Cited by 392 · cited 1×
“Notably, genes such as PINK1 and Parkin, which are related to familial-PD forms, are involved in the control of mitochondrial dynamics [74] and several other genetic mutations, including PINK1, Parkin, DJ-1, LRRK2, and α-Syn, have been linked to familial PD and the corresponding gene products are also involved in mito…”
BackgroundNeuronal degeneration and mitochondrial dysfunction
Schon, E. A., & Manfredi, G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17741 · Cited by 392 · cited 1×
“In particular, mitochondrial dysfunctions (both affecting neuronal survival and triggering neuroinflammation) have been reported in Alzheimer’s (AD), Parkinson’s (PD), and Huntington’s (HD) diseases, Amyotrophic Lateral Sclerosis (ALS), and Spinal Muscular Atrophy (SMA), thus representing a potential biomarker of the…”
BackgroundMitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling
Wu, Y., Chen, M., & Jiang, J. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.07.003 · Cited by 385
New insights into the complex role of mitochondria in Parkinson’s disease
Grünewald, A., Kumar, K. R., & Sue, C. M. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.09.003 · Cited by 364
Motor neurons and the generation of spinal motor neuron diversity
Stifani, N. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00293 · Cited by 351
Elfawy, H. A., & Das, B. (2019) · Life Sciences · doi:10.1016/j.lfs.2018.12.029 · Cited by 343
Transethnic Genetic-Correlation Estimates from Summary Statistics
Brown, B. C., Ye, C. J., Price, A. L., & Zaitlen, N. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.05.001 · Cited by 340
Limitations of current Parkinson's disease therapy
Rascol, O., Payoux, P., Ory, F., Ferreira, J. J., Brefel-Courbon, C., & Montastruc, J.-L. (2003) · Annals of Neurology · doi:10.1002/ana.10513 · Cited by 337
Schöndorf, D. C., Ivanyuk, D., Baden, P., Sanchez-Martinez, A., De Cicco, S., Yu, C., Giunta, I., Schwarz, L. K., Di Napoli, G., Panagiotakopoulou, V., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.009 · Cited by 337 · cited 2×
“Nicotinamide Riboside PD Preclinical in vitro PMID: 29874584 [64] Mitochondrial biogenesis and bioenergetics enhancement; MMP reduction; downregulation of ROS formation”
BackgroundOnasemnogene Abeparvovec: First Global Approval
Hoy, S. M. (2019) · Drugs · doi:10.1007/s40265-019-01162-5 · Cited by 337
Mitochondrial association of alpha-synuclein causes oxidative stress
Parihar, M. S., Parihar, A., Fujita, M., Hashimoto, M., & Ghafourifar, P. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7589-1 · Cited by 330 · cited 1×
“Moreover, α-synuclein oligomers accumulation induces the permeabilization of the mitochondrial membrane and direct toxicity by increasing ROS production and consequently leading to neuronal death [69].”
BackgroundNeuronal degeneration and mitochondrial dysfunction
Schon, E. A., & Manfredi, G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317741 · Cited by 326
Pandi-Perumal, S. R., BaHammam, A. S., Brown, G. M., Spence, D. W., Bharti, V. K., Kaur, C., Hardeland, R., & Cardinali, D. P. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9337-4 · Cited by 320
Tan, D.-X., Manchester, L. C., Reiter, R. J., Plummer, B. F., Hardies, L. J., Weintraub, S. T., Vijayalaxmi, & Shepherd, A. M. M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9826 · Cited by 319
Mitochondrial Dysfunctions in Neurodegenerative Diseases: Relevance to Alzheimer’s Disease
Hroudová, J., Singh, N., & Fišar, Z. (2014) · BioMed Research International · doi:10.1155/2014/175062 · Cited by 318 · cited 1×
“Mitochondria appear morphologically and functionally altered, impacting on many processes such as excessive ROS formation, and resulting in the decrease of brain energy because of the reduction of ATP [47], alteration of calcium homeostasis, and of apoptosis induction [48]: indeed, altered levels of apoptotic markers…”
BackgroundAn SMN-Dependent U12 Splicing Event Essential for Motor Circuit Function
Lotti, F., Imlach, W. L., Saieva, L., Beck, E. S., Hao, L. T., Li, D. K., Jiao, W., Mentis, G. Z., Beattie, C. E., McCabe, B. D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.012 · Cited by 316
Current and future treatments in Alzheimer’s disease
Atri, A. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1678581 · Cited by 309
Keene, C. D., Rodrigues, C. M. P., Eich, T., Chhabra, M. S., Steer, C. J., & Low, W. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162362299 · Cited by 306
Nusinersen: First Global Approval
Hoy, S. M. (2017) · Drugs · doi:10.1007/s40265-017-0711-7 · Cited by 297
Mitochondrial Approaches for Neuroprotection
Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294 · cited 1×
“Additionally, also in PD, mitochondrial dysfunctions are not limited to CNS, but also involve peripheral tissues as it has been described in skeletal muscles and platelets [62,75].”
BackgroundMUNSAT, T. L. (1979) · Neurology · doi:10.1212/wnl.29.4.530-a · Cited by 292
Mitochondrial Dysfunction and Multiple Sclerosis
Barcelos, I. P. D., Troxell, R. M., & Graves, J. S. (2019) · Biology · doi:10.3390/biology8020037 · Cited by 291
Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
Tardiolo, G., Bramanti, P., & Mazzon, E. (2018) · Molecules · doi:10.3390/molecules23123305 · Cited by 285
Reduced oxidative damage in ALS by high‐dose enteral melatonin treatment
Weishaupt, J. H., Bartels, C., Pölking, E., Dietrich, J., Rohde, G., Poeggeler, B., Mertens, N., Sperling, S., Bohn, M., Hüther, G., et al. (2006) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00377.x · Cited by 282
The choreography of neuroinflammation in Huntington's disease
Crotti, A., & Glass, C. K. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.04.007 · Cited by 276 · cited 1×
“Altogether, these mitochondria-derived defects recall pro-inflammatory activated innate immune cells; indeed, in HD, a remarkable neuroinflammation has been observed in brains from HD patients and PET imaging showed that microglia activation correlates with the pathology progression (for an extensive review on the sub…”
BackgroundMitochondria as Potential Targets in Alzheimer Disease Therapy: An Update
Cenini, G., & Voos, W. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00902 · Cited by 257
Mitochondrial Alterations in the Spinal Cord of Patients With Sporadic Amyotrophic Lateral Sclerosis
Sasaki, S., & Iwata, M. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802c396b · Cited by 256 · cited 1×
“For sure, mitochondrial-dependent dysfunctions such as ATP deprivation, oxidative stress, impaired cell signaling together with altered mitochondrial morphology/dynamics are also correlated to the pathogenesis of ALS and represent very early phenomena [99].”
BackgroundReactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis
Schiffer, D., Cordera, S., Cavalla, P., & Migheli, A. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00073-1 · Cited by 255 · cited 1×
“Inflammatory changes have been largely described in ALS patients: astrogliosis is evident within the spinal cord (both ventral and dorsal horns) and brain (cortical gray matter and subcortical white matter), whereas microgliosis in the spinal cord ventral horns, corticospinal tract, and motor cortex [97,98].”
BackgroundWirth, B., Karakaya, M., Kye, M. J., & Mendoza-Ferreira, N. (2020) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-102319-103602 · Cited by 255
Brown, T. A., Tkachuk, A. N., Shtengel, G., Kopek, B. G., Bogenhagen, D. F., Hess, H. F., & Clayton, D. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05694-11 · Cited by 250 · cited 1×
“Interestingly, mitochondria possess their own genome, the mitochondrial DNA (mtDNA), packed in nucleoids in the mitochondrial matrix in close association with the mitochondrial inner membrane [2].”
BackgroundInflammation and Adaptive Immunity in Parkinson's Disease
Mosley, R. L., Hutter-Saunders, J. A., Stone, D. K., & Gendelman, H. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009381 · Cited by 247
Mitochondrial Ca2+ as a key regulator of cell life and death
Giacomello, M., Drago, I., Pizzo, P., & Pozzan, T. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402147 · Cited by 245 · cited 1×
“Importantly, mitochondria buffer calcium ions regulate, in turn, calcium homeostasis [7,8].”
BackgroundMemantine for the Treatment of Dementia: A Review on its Current and Future Applications
Folch, J., Busquets, O., Ettcheto, M., Sánchez-López, E., Castro-Torres, R. D., Verdaguer, E., Garcia, M. L., Olloquequi, J., Casadesús, G., Beas-Zarate, C., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170672 · Cited by 245
Schwarzschild, M. A., Ascherio, A., Beal, M. F., Cudkowicz, M. E., Curhan, G. C., Hare, J. M., Hooper, D. C., Kieburtz, K. D., Macklin, E. A., Oakes, D., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5528 · Cited by 243
The Energetics of Huntington's Disease
Browne, S. E., & Beal, M. F. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000014824.04728.dd · Cited by 240
Uittenbogaard, M., & Chiaramello, A. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140305224906 · Cited by 239
Astrocytes: Conductors of the Alzheimer disease neuroinflammatory symphony
Medeiros, R., & LaFerla, F. M. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.10.007 · Cited by 236 · cited 1×
“In AD there is also evidence of neuroinflammation; indeed, microglia and reactive astrocytes are closely associated with amyloid plaques in patients’ brains [46].”
BackgroundThe Role of Mitochondria in Inflammation: From Cancer to Neurodegenerative Disorders
Missiroli, S., Genovese, I., Perrone, M., Vezzani, B., Vitto, V. A. M., & Giorgi, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030740 · Cited by 234 · cited 1×
“Interestingly, neuroinflammation is closely related to mitochondria [33]: indeed, mitochondria can regulate inflammatory signaling and can modulate the innate immunity by generating ROS and, as a consequence, triggering neurodegeneration [34].”
BackgroundLoss of Mitochondrial Fission Depletes Axonal Mitochondria in Midbrain Dopamine Neurons
Berthet, A., Margolis, E. B., Zhang, J., Hsieh, I., Zhang, J., Hnasko, T. S., Ahmad, J., Edwards, R. H., Sesaki, H., Huang, E. J., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0930-14.2014 · Cited by 229 · cited 2×
“Furthermore, mitochondrial fragmentation, which occurs rapidly after the loss of membrane potential, has been observed in PD: indeed, many proteins involved in fusion and fission (such as the dynamin-related protein 1 (DRP1)) are altered in a model of familial PD [73].”
BackgroundTauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
Elia, A. E., Lalli, S., Monsurrò, M. R., Sagnelli, A., Taiello, A. C., Reggiori, B., La Bella, V., Tedeschi, G., & Albanese, A. (2016) · European Journal of Neurology · doi:10.1111/ene.12664 · Cited by 225
Mitochondrial Ca 2+ uptake contributes to buffering cytoplasmic Ca 2+ peaks in cardiomyocytes
Drago, I., De Stefani, D., Rizzuto, R., & Pozzan, T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210718109 · Cited by 218 · cited 1×
“This is a crucial mitochondrial function impacting many cellular pathways such as the neurotransmitters’ release from neurons and glial cells [9].”
BackgroundMechanisms and roles of mitophagy in neurodegenerative diseases
Wang, Y., Liu, N., & Lu, B. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13140 · Cited by 213 · cited 1×
“Different studies showed that various proteins involved in the above-mentioned processes and in mitophagy are affected in neurodegenerative diseases determining a dysregulation of these processes [30].”
BackgroundThe genetics of Parkinson's syndromes: a critical review
Hardy, J., Lewis, P., Revesz, T., Lees, A., & Paisan-Ruiz, C. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.03.008 · Cited by 209 · cited 1×
“Patients show a progressive muscle rigidity and tremors due to decrease in dopaminergic modulation on striatal neurons altering motor systems [56,57].”
BackgroundResveratrol Improves Motoneuron Function and Extends Survival in SOD1G93A ALS Mice
Mancuso, R., del Valle, J., Modol, L., Martinez, A., Granado-Serrano, A. B., Ramirez-Núñez, O., Pallás, M., Portero-Otin, M., Osta, R., & Navarro, X. (2014) · Neurotherapeutics · doi:10.1007/s13311-013-0253-y · Cited by 206
Mitochondrial dysfunction in amyotrophic lateral sclerosis
Shi, P., Gal, J., Kwinter, D. M., Liu, X., & Zhu, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.012 · Cited by 205 · cited 1×
“In ALS, the apoptotic cascade is activated [101] and the mutant SOD1 is playing a major role in this cascade by interacting with Bcl-2 [102].”
BackgroundMitophagy confers resistance to siderophore-mediated killing by Pseudomonas aeruginosa
Kirienko, N. V., Ausubel, F. M., & Ruvkun, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424954112 · Cited by 200 · cited 1×
“Finally, mitochondria are also able to protect cell integrity by preventing the damage induced by viral infection [16]; indeed, they can also stimulate the innate immune response against these insults [17].”
BackgroundAntioxidant Defense: Vitamins E and C and Carotenoids
Stahl, W., & Sies, H. (1997) · Diabetes · doi:10.2337/diab.46.2.s14 · Cited by 197
Melatonin: Clinical Perspectives in Neurodegeneration
Cardinali, D. P. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00480 · Cited by 197
Dangouloff, T., & Servais, L. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s172291 · Cited by 196
Serendipity and the Discovery of Novel Compounds That Restore Mitochondrial Plasticity
Szeto, H. H., & Birk, A. V. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.174 · Cited by 188
Cassarino, D. S., Fall, C. P., Smith, T. S., & Bennett, J. P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010295.x · Cited by 183
A Cell Biological Perspective on Alzheimer's Disease
Annaert, W., & De Strooper, B. (2002) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.18.020402.142302 · Cited by 182 · cited 1×
“The first evidence of pathogenic mechanisms in AD has been the progressive accumulation of beta-amyloid peptide (Aβ) extracellularly in the brain and of neurofibrillary tangles of hyperphosphorylated tau inside neurons [43], determining the progressive loss of cortical and hippocampal neurons and inducing brain atroph…”
BackgroundDiabetes mellitus in Huntington disease
Farrer, L. A. (1985) · Clinical Genetics · doi:10.1111/j.1399-0004.1985.tb00185.x · Cited by 170 · cited 1×
“Moreover, HD patients show a high predisposition to diabetes and muscle wasting, actually before neurodegeneration [88,89].”
BackgroundFiorani, M., Guidarelli, A., Blasa, M., Azzolini, C., Candiracci, M., Piatti, E., & Cantoni, O. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.01.014 · Cited by 169
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis
Turner, M. R., Bowser, R., Bruijn, L., Dupuis, L., Ludolph, A., McGrath, M., Manfredi, G., Maragakis, N., Miller, R. G., Pullman, S. L., et al. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.778554 · Cited by 168 · cited 1×
“ALS is a neurodegenerative disorder due to the loss of upper and lower motor neurons (MNs) which entails muscle atrophy, progressive weakness, and respiratory failure leading to death [92].”
BackgroundDefective mitochondrial fission augments NLRP3 inflammasome activation
Park, S., Won, J.-H., Hwang, I., Hong, S., Lee, H. K., & Yu, J.-W. (2015) · Scientific Reports · doi:10.1038/srep15489 · Cited by 164 · cited 1×
“Another mechanism by which mitochondria trigger and sustain neuroinflammation is closely related to their dynamism: indeed, the inhibition/stimulation of fission induces/reduces NLRP3 inflammasome assembly and activation, respectively [38].”
BackgroundPagliardini, S. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.1.47 · Cited by 159
Miquel, E., Cassina, A., Palma, L. M., Souza, J. M., Bolatto, C., Rodríguez-Bottero, S., Logan, A., Smith, R. A. J., Murphy, M. P., Barbeito, L., et al. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.019 · Cited by 157
Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications
Cozzolino, M., Ferri, A., & Teresa Carrì, M. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1760 · Cited by 156 · cited 1×
“However, the etiology of the disease is not yet understood: it includes excitotoxicity, protein misfolding and aggregation, dysregulation of RNA metabolism, and neuroinflammation [96].”
BackgroundImpaired GAPDH‐induced mitophagy contributes to the pathology of Huntington's disease
Hwang, S., Disatnik, M., & Mochly‐Rosen, D. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505256 · Cited by 153 · cited 1×
“Several studies have revealed reduced mitophagy in the brain of HD patients [81].”
BackgroundMyhre, O., Utkilen, H., Duale, N., Brunborg, G., & Hofer, T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/726954 · Cited by 152
Pollari, E., Goldsteins, G., Bart, G., Koistinaho, J., & Giniatullin, R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00131 · Cited by 150
Mitochondria in Amyotrophic Lateral Sclerosis: A Trigger and a Target
Dupuis, L., Gonzalez de Aguilar, J.-L., Oudart, H., de Tapia, M., Barbeito, L., & Loeffler, J.-P. (2004) · Neurodegenerative Diseases · doi:10.1159/000085063 · Cited by 149
Cardiac dysfunction in the R6/2 mouse model of Huntington’s disease
Mihm, M. J., Amann, D. M., Schanbacher, B. L., Altschuld, R. A., Bauer, J. A., & Hoyt, K. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.09.016 · Cited by 149 · cited 1×
“In this regard, impaired uptake and levels of glucose and cardiac dysfunctions have been shown in HD mouse models [86,87].”
BackgroundYin, X., Manczak, M., & Reddy, P. H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw045 · Cited by 141 · cited 1×
“Neurodegenerative diseases consist of a group of heterogeneous disorders, but, nevertheless, they are all characterized by the progressive loss of specific neuronal populations and circuits in the central nervous system (CNS) triggered by mitochondria dysfunctions [23,24].”
BackgroundOlesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound
Bordet, T., Berna, P. P., Abitbol, J., & Pruss, R. M. (2010) · Pharmaceuticals · doi:10.3390/ph3020345 · Cited by 140
Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy
Ripolone, M., Ronchi, D., Violano, R., Vallejo, D., Fagiolari, G., Barca, E., Lucchini, V., Colombo, I., Villa, L., Berardinelli, A. L., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0178 · Cited by 140
Remington, R., Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y., Smyers, K., Page, R., Morrell, C., et al. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142499 · Cited by 134
Fortune, M. D., Guo, H., Burren, O., Schofield, E., Walker, N. M., Ban, M., Sawcer, S. J., Bowes, J., Worthington, J., Barton, A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3330 · Cited by 133
Inflammation in ALS and SMA: Sorting out the good from the evil
Papadimitriou, D., Le Verche, V., Jacquier, A., Ikiz, B., Przedborski, S., & Re, D. B. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.005 · Cited by 132
Iturria-Medina, Y., Carbonell, F. M., Sotero, R. C., Chouinard-Decorte, F., & Evans, A. C. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.02.058 · Cited by 130
Langley, M., Ghosh, A., Charli, A., Sarkar, S., Ay, M., Luo, J., Zielonka, J., Brenza, T., Bennett, B., Jin, H., et al. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6905 · Cited by 130
Intracellular pH Modulates Autophagy and Mitophagy
Berezhnov, A. V., Soutar, M. P. M., Fedotova, E. I., Frolova, M. S., Plun-Favreau, H., Zinchenko, V. P., & Abramov, A. Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.691774 · Cited by 129
Anaplerotic diet therapy in inherited metabolic disease: Therapeutic potential
Roe, C. R., & Mochel, F. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0290-3 · Cited by 128
Application and prospects of butylphthalide for the treatment of neurologic diseases
Chen, X., Qiu, K., Liu, H., He, Q., Bai, J.-H., & Lu, W. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000289 · Cited by 128
Kook, S.-Y., Lee, K.-M., Kim, Y., Cha, M.-Y., Kang, S., Baik, S. H., Lee, H., Park, R., & Mook-Jung, I. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.26 · Cited by 127
Cardiac pathology in spinal muscular atrophy: a systematic review
Wijngaarde, C. A., Blank, A. C., Stam, M., Wadman, R. I., van den Berg, L. H., & van der Pol, W. L. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0613-5 · Cited by 127
Acevedo-Torres, K., Berríos, L., Rosario, N., Dufault, V., Skatchkov, S., Eaton, M. J., Torres-Ramos, C. A., & Ayala-Torres, S. (2009) · DNA Repair · doi:10.1016/j.dnarep.2008.09.004 · Cited by 126 · cited 1×
“Moreover, accumulation of mtDNA defects occurs early in HD to the point of being suggested as a potential biomarker of the disease [82,83].”
BackgroundEschbach, J., von Einem, B., Müller, K., Bayer, H., Scheffold, A., Morrison, B. E., Rudolph, K. L., Thal, D. R., Witting, A., Weydt, P., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24294 · Cited by 125
Zhu, C. W., Grossman, H., Neugroschl, J., Parker, S., Burden, A., Luo, X., & Sano, M. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.09.009 · Cited by 125
Naturally occurring deuterium is essential for the normal growth rate of cells
Somlyai, G., Jancsó, G., Jákli, G., Vass, K., Barna, B., Lakics, V., & Gaál, T. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81479-j · Cited by 123 · cited 1×
“Deuterium is a hydrogen isotope, present in nature in a well-defined ratio with hydrogen (1:6600) [26]: in body fluids, the probability of ATP synthase deuteronation process is 1/15,000 and the increase of this ratio can negatively interfere with ATP synthesis.”
BackgroundMultiple pathways contribute to the pathogenesis of Huntington disease.
Li, S., & Li, X. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-19 · Cited by 122
Bile Acids in Neurodegenerative Disorders
Ackerman, H. D., & Gerhard, G. S. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00263 · Cited by 120
Young, M. L., & Franklin, J. L. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103409 · Cited by 120
Delivery of proteins and organelles to the vacuole from the cytoplasm
Scott, S. V., & Klionsky, D. J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80068-9 · Cited by 119 · cited 1×
“Described for the first time in 1998 [31], mitophagy has gained considerable interest in the field of neurodegeneration in the last years; however, because of its fine tuning, it is a difficult target for designing new therapies against neurodeg neration.”
BackgroundXi, Y., Feng, D., Tao, K., Wang, R., Shi, Y., Qin, H., Murphy, M. P., Yang, Q., & Zhao, G. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.05.018 · Cited by 117
Vitamin E and Alzheimer’s disease: what do we know so far?
Browne, D., McGuinness, B., Woodside, J. V., & McKay, G. J. (2019) · Clinical Interventions in Aging · doi:10.2147/cia.s186760 · Cited by 114
Nicholls, D. G., Vesce, S., Kirk, L., & Chalmers, S. (2003) · Cell Calcium · doi:10.1016/s0143-4160(03)00144-1 · Cited by 111 · cited 1×
“Importantly, mitochondria buffer calcium ions regulate, in turn, calcium homeostasis [7,8].”
BackgroundRole of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis
Tan, W., Pasinelli, P., & Trotti, D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.02.009 · Cited by 110
Ghosh, A., Langley, M. R., Harischandra, D. S., Neal, M. L., Jin, H., Anantharam, V., Joseph, J., Brenza, T., Narasimhan, B., Kanthasamy, A., et al. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9650-4 · Cited by 108
Xiong, N., Huang, J., Chen, C., Zhao, Y. Y., Zhang, Z., Jia, M., Zhang, Z., Hou, L., Yang, H., Cao, X., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.007 · Cited by 107
Jiang, W., Luo, T., Li, S., Zhou, Y., Shen, X.-Y., He, F., Xu, J., & Wang, H.-Q. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152371 · Cited by 104
Mathew, A., Lindsley, T. A., Sheridan, A., Bhoiwala, D. L., Hushmendy, S. F., Yager, E. J., Ruggiero, E. A., & Crawford, D. R. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120145 · Cited by 103 · cited 1×
“Interestingly, neuroinflammation is closely related to mitochondria [33]: indeed, mitochondria can regulate inflammatory signaling and can modulate the innate immunity by generating ROS and, as a consequence, triggering neurodegeneration [34].”
BackgroundMitochondrial dysfunction in a neural cell model of spinal muscular atrophy
Acsádi, G., Lee, I., Li, X., Khaidakov, M., Pecinová, A., Parker, G. C., & Hüttemann, M. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22106 · Cited by 102
Triheptanoin improves brain energy metabolism in patients with Huntington disease
Adanyeguh, I. M., Rinaldi, D., Henry, P.-G., Caillet, S., Valabregue, R., Durr, A., & Mochel, F. (2015) · Neurology · doi:10.1212/wnl.0000000000001214 · Cited by 101
Role of microglial redox balance in modulation of neuroinflammation
Innamorato, N. G., Lastres-Becker, I., & Cuadrado, A. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832a3225 · Cited by 100
Urate as a Marker of Risk and Progression of Neurodegenerative Disease
Paganoni, S., & Schwarzschild, M. A. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0497-4 · Cited by 100
Brenza, T. M., Ghaisas, S., Ramirez, J. E. V., Harischandra, D., Anantharam, V., Kalyanaraman, B., Kanthasamy, A. G., & Narasimhan, B. (2017) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2016.10.004 · Cited by 99
Drug Development for the Therapy of Mitochondrial Diseases
Weissig, V. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.09.002 · Cited by 98
Bell, S. M., Barnes, K., Clemmens, H., Al-Rafiah, A. R., Al-ofi, E. A., Leech, V., Bandmann, O., Shaw, P. J., Blackburn, D. J., Ferraiuolo, L., et al. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.08.019 · Cited by 97
Mitochondria-Targeted Antioxidant Peptides
Rocha, M., Hernandez-Mijares, A., Garcia-Malpartida, K., Banuls, C., Bellod, L., & M. Victor, V. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793292519 · Cited by 96
Daruich, A., Picard, É., Boatright, J. H., & Béhar‐Cohen, F. (2019) · Molecular vision · Cited by 96
Boyd, P. J., Tu, W.-Y., Shorrock, H. K., Groen, E. J. N., Carter, R. N., Powis, R. A., Thomson, S. R., Thomson, D., Graham, L. C., Motyl, A. A. L., et al. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006744 · Cited by 95
Harlan, B. A., Pehar, M., Sharma, D. R., Beeson, G., Beeson, C. C., & Vargas, M. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698779 · Cited by 94
Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review
Carrera‐Juliá, S., Moreno, M. L., Barrios, C., Ortí, J. E. D. L. R., & Drehmer, E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00063 · Cited by 93
Pérez, M. J., Ponce, D. P., Aranguiz, A., Behrens, M. I., & Quintanilla, R. A. (2018) · Redox Biology · doi:10.1016/j.redox.2018.09.001 · Cited by 90 · cited 1×
“There is a vast literature on the detrimental impact of the accumulation of damage and misfolded proteins inducing dysfunctions at the cellular and mitochondrial level not only in the NS but also in peripheral tissues such as patients fibroblasts [51] which show mitochondrial calcium dysregulation similar to those occ…”
BackgroundMitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer’s Disease?
dos Santos, S. M., Romeiro, C. F. R., Rodrigues, C. A., Cerqueira, A. R. L., & Monteiro, M. C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8409329 · Cited by 88
Lim, J. L., Wilhelmus, M. M. M., de Vries, H. E., Drukarch, B., Hoozemans, J. J. M., & van Horssen, J. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1338-z · Cited by 86
Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy
Boido, M., & Vercelli, A. (2016) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2016.00006 · Cited by 85
Self-citationSearls, R. L., & Sanadi, D. R. (1960) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64646-0 · Cited by 84
Mitochondrial dysfunction in central nervous system white matter disorders
Morató, L., Bertini, E., Verrigni, D., Ardissone, A., Ruíz, M., Ferrer, I., Uziel, G., & Pujol, A. (2014) · Glia · doi:10.1002/glia.22670 · Cited by 81
Koh, S. H., Kwon, H., Kim, K. S., Kim, J., Kim, M.-H., Yu, H.-J., Kim, M., Lee, K. W., Rok, B., Jung, H. K., et al. (2004) · Toxicology · doi:10.1016/j.tox.2004.05.008 · Cited by 81
Rudnitskaya, E. A., Muraleva, N. A., Maksimova, K. Y., Kiseleva, E., Kolosova, N. G., & Stefanova, N. A. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150161 · Cited by 81
Lee, J. G., Woo, Y. S., Park, S. W., Seog, D., Seo, M. K., & Bahk, W. (2019) · Brain Sciences · doi:10.3390/brainsci9100285 · Cited by 81
Busse, M. E., Hughes, G., Wiles, C. M., & Rosser, A. E. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0964-x · Cited by 80 · cited 1×
“Moreover, HD patients show a high predisposition to diabetes and muscle wasting, actually before neurodegeneration [88,89].”
BackgroundIntracellular pH Modulates Autophagy and Mitophagy
Berezhnov, A., Soutar, M. P. M., Fedotova, E., Frolova, M., Plun‐Favreau, H., Zinchenko, V., & Abramov, A. Y. (2016) · UCL Discovery (University College London) · Cited by 80
Beneficial effects of melatonin in experimental models of Alzheimer disease1
CHENG, Y., Zheng, F., ZHANG, Q.-Z., & ZHANG, J.-T. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00267.x · Cited by 78
Shu, L., Chan, K. H. K., Zhang, G., Huan, T., Kurt, Z., Zhao, Y., Codoni, V., Trégouët, D.-A., Cardiogenics Consortium, Yang, J., et al. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1007040 · Cited by 78
Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development
Cutler, N. R., & Sramek, J. J. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00147-0 · Cited by 77
Protective Activity of Aromatic Amines and Imines against Oxidative Nerve Cell Death
Moosmann, B., Skutella, T., Beyer, K., & Behl, C. (2001) · Biological Chemistry · doi:10.1515/bc.2001.195 · Cited by 77
Stefanova, N. A., Muraleva, N. A., Maksimova, K. Y., Rudnitskaya, E. A., Kiseleva, E., Telegina, D. V., & Kolosova, N. G. (2016) · Aging · doi:10.18632/aging.101054 · Cited by 77
Xu, C.-C., Denton, K. R., Wang, Z.-B., Zhang, X., & Li, X. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.021766 · Cited by 76
Sayeed, I., Parvez, S., Winkler‐Stuck, K., Seitz, G., Trieu, I., Wallesch, C.-W., Schönfeld, P., & Siemen, D. (2006) · The FASEB Journal · doi:10.1096/fj.05-4748fje · Cited by 75
Bcl-2 proteins bid and bax form a network to permeabilize the mitochondria at the onset of apoptosis
Gahl, R. F., Dwivedi, P., & Tjandra, N. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.320 · Cited by 75 · cited 1×
“Indeed, mitochondria can induce apoptosis via caspase-dependent or independent mechanisms, the first by the activation of pro-apoptotic members of the B-cell lymphoma 2 (Bcl-2) family, the latter by the release of toxic mitochondrial proteins occurring after mitochondrial loss of function [11].”
BackgroundAl-Amin, M. M., Akhter, S., Hasan, A. T., Alam, T., Hasan, S. M. N., Saifullah, A. R. M., & Shohel, M. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9699-4 · Cited by 73
Hemachandra Reddy, P., Charles, V., Williams, M., Miller, G., Whetsell, W. O., & Tagle, D. A. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0456 · Cited by 72 · cited 1×
“The huntingtin protein (HTT) is involved in many processes such as axonal transport, signal transduction, and autophagy; its misfolding due to HTT mutation determines the disruption of the above-mentioned biological processes and of many others [77].”
BackgroundRole of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia
Carvalho, C., Correia, S. C., Santos, R. X., Cardoso, S., Moreira, P. I., Clark, T. A., Zhu, X., Smith, M. A., & Perry, G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9247-1 · Cited by 72 · cited 1×
“Mitochondria appear morphologically and functionally altered, impacting on many processes such as excessive ROS formation, and resulting in the decrease of brain energy because of the reduction of ATP [47], alteration of calcium homeostasis, and of apoptosis induction [48]: indeed, altered levels of apoptotic markers…”
BackgroundSimone, C., Ramirez, A., Bucchia, M., Rinchetti, P., Rideout, H., Papadimitriou, D., Re, D. B., & Corti, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2106-9 · Cited by 71
Monitoring clinical progression with mitochondrial disease biomarkers
Steele, H. E., Horváth, R., Lyon, J. J., & Chinnery, P. F. (2017) · Brain · doi:10.1093/brain/awx168 · Cited by 70 · cited 1×
“Mutations at the mtDNA level are causative for many human diseases which are generally defined as mitochondrial disorders [3].”
BackgroundIncreased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients
Borgia, D., Malena, A., Spinazzi, M., Desbats, M. A., Salviati, L., Russell, A. P., Miotto, G., Tosatto, L., Pegoraro, E., Sorarú, G., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx019 · Cited by 68
Nrf2 Signaling Contributes to the Neuroprotective Effects of Urate against 6-OHDA Toxicity
Zhang, N., Shu, H., Huang, T., Zhang, Q., Li, D., Zhang, G., Peng, X., Liu, C., Luo, W., & Hu, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100286 · Cited by 67
Shared mechanisms among neurodegenerative diseases: from genetic factors to gene networks
Arneson, D., Zhang, Y., Yang, X., & Narayanan, M. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0963-3 · Cited by 67
Deuterium-Depleted Water Influence on the Isotope 2H/1H Regulation in Body and Individual Adaptation
Басов, А. А., Fedulova, L., Baryshev, M., & Dzhimak, S. S. (2019) · Nutrients · doi:10.3390/nu11081903 · Cited by 67 · cited 1×
“Indeed, DDW is able to promote antioxidant enzymes’ expression (SOD) and restore glutathione (GSH) levels mitigating, in turn, ROS formation and preventing fatty acid oxidation [29].”
Background
Cited by
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease
Misrani, A., Tabassum, S., & Yang, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.617588 · Cited by 654
Homocysteine and Mitochondria in Cardiovascular and Cerebrovascular Systems
Kaplan, P., Tatarkova, Z., Sivonova, M. K., Racay, P., & Lehotsky, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207698 · Cited by 196
“of the above-mentioned neurodegenerative and cardiovascular diseases [22].”
BackgroundDeregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Gowda, P., Reddy, P. H., & Kumar, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101529 · Cited by 163
Antioxidant Effects of Protocatechuic Acid and Protocatechuic Aldehyde: Old Wine in a New Bottle
Zhang, S., Gai, Z., Gui, T., Chen, J., Chen, Q., & Li, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6139308 · Cited by 156
“PCA is also regarded as the perfect peroxyl radical scavenger in the polar environment of aqueous solutions and a relatively good anti-radical protector in nonpolar environment of lipid solutions [92].”
BackgroundFields, M., Marcuzzi, A., Gonelli, A., Celeghini, C., Maximova, N., & Rimondi, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043739 · Cited by 156
“[4] determined that mitochondrial dysfunctions represent a crucial point of convergence in the pathogenesis of such neurodegenerative pathologies.”
Background
Metadata
- Authors
- Stanga, S., Caretto, A., Boido, M., & Vercelli, A.
- Affiliations
- Neuroscience Institute Cavalieri Ottolenghi (IT)
- Corresponding author
- Stanga, Serena
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-05-25
- Volume
- 21
- Issue
- 10
- Pages
- 3719
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7279270
- OpenAlex
- W3026090014
- Cited by
- 90
- References
- 244
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 10 · 2023: 8 · 2022: 18 · 2021: 23 · 2020: 10
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministero dell’Istruzione, dell’Università e della Ricerca (“Dipartimenti di Eccellenza 2018–2022” to Department of Neuroscience “Rita Levi Montalcini)
- Fondazione CRT (RF 2017.2052)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- mitochondrial dysfunction, neurodegenerative diseases, neurodegeneration, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, spinal muscular atrophy, mitochondrial morphology, mitochondrial-targeted drugs, cellular senescence, DNA damage
- MeSH terms
- Alzheimer Disease, Amyotrophic Lateral Sclerosis, Animals, Antioxidants, Organelle Biogenesis, Humans, Mitochondria, Muscular Atrophy, Spinal, Parkinson Disease, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.